Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T12:25:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record with a generic access-block page.
    Difference
    16%
    Check dated 2026-09-19T20:21:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.6.5 to v3.6.6, signaling a new software release. This change does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-29T21:52:50.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 to reflect a routine update to the page's software version.
    Difference
    0.0%
    Check dated 2026-08-08T22:43:45.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, reflecting an update to the page's underlying system or template.
    Difference
    0.0%
    Check dated 2026-07-25T13:05:50.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page shows added and removed date markers (e.g., 2026-07-17, 2026-07-16, 2026-07) indicating update timestamps for the study record, suggesting administrative maintenance rather than content changes. This reflects maintenance activity rather than alterations to the trial information.
    Difference
    0.1%
    Check dated 2026-07-18T09:29:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.